This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Cholecystitis

Authoring team

Cholecystitis is inflammation of the gallbladder. It is a major complication of cholelithiasis (i.e. gallstones). Symptomatic gallstones are common before cholecystitis develops.

The most common cause is gallstones, accounting for 95% of cases:

  • about 1% to 2% of people with asymptomatic gallstones become symptomatic each year. (1) Acute cholecystitis occurs in about 10% of symptomatic patients (2)
  • is 3 times more common in women than in men up to the age of 50 years, and is about 1.5 times more common in women than in men over the age of 50 (3)

Less commonly, cholecystitis may result from:

  • trauma
  • surgery
  • primary infection, e.g. from Salmonella typhi - the typhoid gallbladder - or from Ascari lumbricoides - ascariasis
  • total parenteral nutrition

References:

  1. Abraham S, Rivero HG, Erlikh IV, et al. Surgical and nonsurgical management of gallstones. Am Fam Physician. 2014 May 15;89(10):795-802.
  2. Ko CW, Lee SP. Gastrointestinal disorders of the critically ill. Biliary sludge and cholecystitis. Best Pract Res Clin Gastroenterol. 2003 Jun;17(3):383-96.
  3. Indar AA, Beckingham IJ. Acute cholecystitis. BMJ. 2002 Sep 21;325(7365):639-43.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.